-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$30.20111.34% Upside
10x Genomics, Inc. Frequently Asked Questions
-
What analysts cover 10x Genomics, Inc.?
10x Genomics, Inc. has been rated by research analysts at Morgan Stanley, Canaccord Genuity, Deutsche Bank, Barclays, Jefferies in the past 90 days.